Trial intelligence / Profile preview

Simvastatin for Alveolar Bone Healing

NCT05369091Phase 4Completed

Sponsor
Postgraduate Medical Institute
Start
Dec 2020
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in bone fracture (Fx) comparing Placebo with Simvastatin (2 arms). Primary endpoints: Salivary Bone Morphogenetic Protein-2 Levels at Day 40 and Radiographic Measurement of Bone Density at Day 40. Started Dec 2020; status: completed.

02

Drugs

simvastatin
03

Conditions

bone fracture (Fx)

Beyond the preview

Go deeper on NCT05369091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05369091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call